TrialJAMA dermatology2020

Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.

Dylan Haynes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.